Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human CD3 (Research Grade Teplizumab Biosimilar) Alexa Fluor 647-conjugated Antibody, R&D Systems™

Human Monoclonal Antibody
Supplier: R&D Systems FAB9929R100UG
This item is not returnable.
View return policy
Description
CD3 Monoclonal specifically detects CD3 in Human samples. It is validated for Flow Cytometry.Specifications
CD3 | |
Monoclonal | |
Alexa Fluor 647 | |
Supplied 0.2 mg/ml in a saline solution containing BSA and Sodium Azide. | |
Human | |
Protein A or G purified from cell culture supernatant | |
Primary | |
Detects Human CD3 based on Teplizumab therapeutic antibody. This non-therapeutic antibody uses the same variable region sequence as the therapeutic antibody Teplizumab. This product is for research use only. | |
Protect from light. Do not freeze. 12 months from date of receipt, 2 to 8 degreesC as supplied. | |
IgG1 |
Flow Cytometry | |
Hu113 | |
Flow Cytometry 0.25-1 μg/10^6 cells | |
CD3 antigen, delta subunit, CD3d antigen, CD3d antigen, delta polypeptide (TiT3 complex), CD3d molecule, delta (CD3-TCR complex), CD3-DELTA, CD3e antigen, CD3e antigen, epsilon polypeptide (TiT3 complex), CD3e molecule, epsilon (CD3-TCR complex), CD3-epsilon, CD3G, CD3g antigen, CD3g antigen, gamma polypeptide (TiT3 complex), CD3g molecule, epsilon (CD3-TCR complex), CD3g molecule, gamma (CD3-TCR complex), CD3-GAMMA, FLJ17620, FLJ17664, FLJ18683, FLJ79544, FLJ94613, MGC138597, T3DOKT3, delta chain, T3E, T-cell antigen receptor complex, epsilon subunit of T3, T-cell receptor T3 delta chain, T-cell surface antigen T3/Leu-4 epsilon chain, T-cell surface glycoprotein CD3 delta chain, T-cell surface glycoprotein CD3 epsilon chain, TCRE | |
Human CD3 | |
100 μg | |
916 | |
Human | |
Supernatant |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction